The Joint Corp. (JYNT) Stock Analysis

Company Overview

The Joint Corp. (JYNT) carries a market capitalisation of $117.67M. It is classified in the Medical Care Facilities industry, within the Healthcare sector. The company reports 202 employees.

Over the past 52 weeks the price has ranged from $7.50 to $10.72. JYNT last closed at $8.32 on September 4, 2026. That is +$0.04 (+0.48%) against the previous close. The latest close sits 10.93% above that 52-week low.

Financial Health

In fiscal 2025, The Joint Corp. reported revenue of $54.90M. That is +5.24% against the prior fiscal year, when revenue was $52.16M. Net income for the same year was $2.91M. The reported profit margin is 6.49%. That is 3.4 percentage points above the Medical Care Facilities median of 3.06%. Earnings per share on a trailing basis come to 0.14.

Across the 4 fiscal years on file, revenue moves from $101.25M in 2022 to $54.90M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 59.43 times earnings. That is 199.55% above the Medical Care Facilities median of 19.84. The forward P/E on file is 13.1. The PEG ratio, which sets the P/E against expected earnings growth, reads 8.83. Measured against sales, the shares trade at 2.01 times revenue. On price-to-sales that is 111.45% above the Medical Care Facilities median of 0.95. The medians here are taken across 57 Medical Care Facilities companies that report the metric.

Beta against the wider market is reported at 1.06. Daily returns over the trailing 10 years annualize to a volatility of 55.63%. The trailing one-year price return is −21.95%. Measured over 10 years, that is +11.51% a year compounded.

Growth & Income

The record shows no dividend for JYNT.

The strongest complete calendar year on file is 2021 at +150.15%; the weakest is 2022 at −78.72%. Of the 9 complete calendar years on file, 6 finished higher. So far in 2026 the price is −4.59%.